Association between renin–angiotensin system inhibitors and COVID-19 complications

• DOI: 10.1093/ehjcvp/pvaa062
• Publication Date: 2020-05-28T11:09:31Z
• Authors: Sophie Liabeuf; Julien Moragny; Youssef Bennis; Benjamin Batteux; Etienne Brochot; Jean Luc Schmit; Jean-Philippe Lanoix; Claire Andrejak; Olivier Ganry; Michel Slama; Julien Maizel; Yazine Mahjoub; Kamel Masmoudi; Valérie Gras-Champel
• Keywords: 2019-20 coronavirus outbreak; Peptidyl-Dipeptidase A

To describe the characteristics of patients hospitalized with COVID-19 (including their long-term at-home medication use), and compare them regard to course disease. assess association between renin-angiotensin system inhibitors (RASIs) disease progression critical outcomes.